(Q44434968)

2 December 2017

title

Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus (English)

1 reference

2 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S1056-8727(02)00204-0

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1056-8727(02)00204-0

31 December 2023

author name string

Dan Streja

1

1 reference

2 December 2017

Pamela Cressey

2

1 reference

2 December 2017

Simon W. Rabkin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738395

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738395

31 December 2023

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S1056872702002040?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1056-8727(02)00204-0

https://api.elsevier.com/content/article/PII:S1056872702002040?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1056-8727(02)00204-0

Journal of Diabetes and its Complications

31 December 2023

published in

1 reference

2 December 2017

volume

17

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

120-127

1 reference

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Association of fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Novel clinical markers of vascular wall inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Evaluation of a new radioimmunoassay for urinary albumin

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Association of fibrinogen with glycemic control and albumin excretion rate in patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Hormone replacement therapy, inflammation, and hemostasis in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

C-reactive protein, inflammation, and coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Inflammatory markers of coronary risk

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Variability in fibrinogen measurements: an obstacle to cardiovascular risk stratification

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Effect of moderate alcohol consumption on fibrinogen levels in healthy volunteers is discordant with effects on C-reactive protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2802%2900204-0

7 January 2021

More on the effect of atorvastatin on plasma fibrinogen levels in primary hypercholesterolaemia

52

1 reference

https://api.crossref.org/works/10.1016/S1056-8727(02)00204-0

31 December 2023

Identifiers

1 reference

2 December 2017

1 reference